Universal Health Coverage of Opioid Agonist Treatment in Norway: An Equity-Adjusted Economic Evaluation

Prayash Chaudhary,Lars Thore Fadnes,Steinar Fosse,Fatemeh Chalabianloo,Kjell Arne Johansson
DOI: https://doi.org/10.1007/s40273-024-01442-3
2024-10-25
PharmacoEconomics
Abstract:Detailed information on the efficiency of health services targeting opioid use disorder (OUD) and treatment with opioid agonist treatment (OAT) is sparse. Many countries, including Norway, are still falling short of universal health coverage (UHC) of OAT. This study aims to evaluate the incremental lifetime costs and effects of treating OUD with OAT as compared to no OAT in Norway and scaling up the treatment to a universal coverage level using equity-adjusted health economic evaluations.
pharmacology & pharmacy,health care sciences & services,health policy & services,economics
What problem does this paper attempt to address?